Daniela Lamers - Concepedia

Concepedia

Author

Daniela Lamers

Deutsches Diabetes-Zentrum e.V.

Also Known As

D Lamers, D. Lamers, DANIELA LAMERS, Daniela Lamers

21

Publications

1.3K

Citations

11

H-Index

29

Concepts

All Affiliations

Deutsches Diabetes-Zentrum e.V.Profil Institute for Metabolic Research Ghent University Hospital Zealand Pharma (Denmark)

DL

About

Daniela Lamers is an author at Deutsches Diabetes-Zentrum e.V. specializing in metabolic regulation, medicine, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	498
2	Health Sciences	4	4	476
3	Cell Biology	4	4	260
4	Biochemistry	1	1	238
5	Cellular Physiology	1	1	68

Daniela Lamers

×

11

Publications

1.3K

Citations

11

H-Index

	Year	Citations
Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome Daniela Lamers, Susanne Famulla, Nina Wronkowitz, Diabetes	2011	574
Identification and Validation of Novel Adipokines Released from Primary Human Adipocytes Stefan Lehr, Sonja Hartwig, Daniela Lamers, Molecular & Cellular Proteomics ObesityMetabolic SyndromeNovel AdipokinesBiochemistryAdipose Tissue	2011	238
Pigment epithelium-derived factor (PEDF) is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cells Susanne Famulla, Daniela Lamers, Sonja Hartwig, International Journal of Obesity InflammationMetabolic SyndromeInsulin SignalingMolecular PhysiologySignal Transduction	2010	154
Pharmacokinetic and Pharmacodynamic Characteristics of Dasiglucagon, a Novel Soluble and Stable Glucagon Analog Ulrike Hövelmann, Britta Væver Bysted, Ulrik Mouritzen, Diabetes Care	2017	108
Oleic acid and adipokines synergize in inducing proliferation and inflammatory signalling in human vascular smooth muscle cells Daniela Lamers, Raphaela Schlich, Sabrina Greulich, Journal of Cellular and Molecular Medicine AdipokinesCellular PhysiologyOxidative StressInflammationMetabolic Syndrome	2010	68
Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon‐like peptide‐1 receptor agonist <scp>BI</scp> 456906 Arvid Jungnik, Jorge Arrubla, Leona Plum‐Mörschel, Diabetes Obesity and Metabolism	2022	56
Ultra‐rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14‐day crossover treatment study in people with type 1 diabetes Grit Andersen, Grégory Meiffren, Daniela Lamers, Diabetes Obesity and Metabolism	2018	37
Low doses of dasiglucagon consistently increase plasma glucose levels from hypoglycaemia and euglycaemia in people with type 1 diabetes mellitus Ulrike Hövelmann, MINNA B. OLSEN, Ulrik Mouritzen, Diabetes Obesity and Metabolism	2018	27
Differential impact of oleate, palmitate, and adipokines on expression of NF-κB target genes in human vascular smooth muscle cells Daniela Lamers, Raphaela Schlich, A Horrighs, Molecular and Cellular Endocrinology InflammationTranscriptional RegulationDifferential ImpactMolecular PhysiologyPhysiology	2012	22
Adipokines enhance oleic acid-induced proliferation of vascular smooth muscle cells by inducing CD36 expression Raphaela Schlich, Daniela Lamers, Jürgen Eckel, Archives of Physiology and Biochemistry Acid-induced ProliferationAdipokinesOxidative StressInflammationMetabolic Syndrome	2015	16

Page 1